# Association between dietary zinc intake and herpes simplex virus seropositivity in U.S. adults: a cross-sectional study

## TL;DR

This study found that moderate dietary zinc intake is linked to lower chances of having herpes simplex virus in U.S. adults.

## Contribution

The study reveals a U-shaped relationship between dietary zinc intake and herpes simplex virus seropositivity, suggesting moderate zinc intake is protective.

## Key findings

- Higher dietary zinc intake was associated with reduced odds of HSV-1 and HSV-2 seropositivity compared to the lowest intake group.
- A U-shaped relationship was observed, indicating that moderate zinc intake is most protective against herpes simplex virus.
- Statistical methods confirmed the protective effect of moderate zinc intake after adjusting for covariates.

## Abstract

Although recent research has demonstrated an association between serum zinc deficiency and susceptibility to various viral infections, the relationship between dietary zinc intake and herpes simplex virus (HSV) seropositivity remains unclear.

The National Health and Nutrition Examination Survey (NHANES) (2007–2016) provides data on HSV-1 and HSV-2 status and dietary zinc intake. The associations between dietary zinc and HSV-1 and HSV-2 were evaluated via various statistical methods, including multivariate logistic regression, restricted cubic spline analysis, and subgroup analysis.

In total, 6,483 individuals were enrolled, with 58.9% (3,817/6,483) testing positive for HSV-1 and 19.3% (1,253/6,483) testing positive for HSV-2. After adjusting for all covariates in the multivariate logistic regression, compared with the lowest zinc intake group (Q1: <7.51 mg/day), the adjusted odds ratios (ORs) for HSV-1 and HSV-2 in the higher-zinc intake groups were as follows: for HSV-1, Q2 (7.51–10.87 mg/day) had an OR of 0.81 (95% confidence interval [CI]: 0.72–0.98, p = 0.027), and Q3 (10.87–15.63 mg/day) had an OR of 0.85 (95% CI: 0.70–1.03, p = 0.093), and Q4 (> 15.63 mg/day) had an OR of 0.84 (95% CI: 0.67–1.04, p = 0.114); for HSV-2, Q2 had an OR of 0.80 (95% CI: 0.64–1.00, p = 0.050), Q3 had an OR of 0.81 (95% CI: 0.64–1.02, p = 0.069), and Q4 had an OR of 0.75 (95.

Dietary zinc intake exhibited a U-shaped association with HSV-1 and HSV-2 seropositivity, indicating that moderate zinc intake has a protective effect.

Not applicable.